Blog
RSS FeedPosted by Michael Wonder on 30 Apr 2020
PBS restriction requirement exemptions for some medicines during the COVID-19 pandemic
30 April 2020 - The Australian Government is implementing a temporary measure from 1 May 2020 to allow some flexibility ...
Posted by Michael Wonder on 30 Apr 2020
Revised PBS restrictions for medicine for pulmonary arterial hypertension
30 April 2020 - The restrictions for medicines listed on the PBS for patients with pulmonary arterial hypertension have been ...
Posted by Michael Wonder on 30 Apr 2020
Updates to antibiotic repeats on the Pharmaceutical Benefits Scheme item (August 2019)
30 April 2020 - Updated listings have been added to the Public Summary Document for the antibiotic repeats on the Pharmaceutical ...
Posted by Michael Wonder on 30 Apr 2020
Procedure Guidance for standardised redactions to PBAC Public Summary Documents
30 April 2020 - The PBAC has indicated its preference for greater transparency to be introduced in PSDs through a ...
Posted by Michael Wonder on 28 Apr 2020
Cost recovery - consultation feedback
28 April 2020 - On 12 February 2020, the Department hosted a webinar to commence broad consultation on proposed fee changes ...
Posted by Michael Wonder on 27 Apr 2020
Insights from the March 2020 PBAC meeting - Dupilumab (Dupixent)
27 April 2020 - Did the PBAC give Sanofi the run around? ...
Posted by Michael Wonder on 27 Apr 2020
Insights from the March 2020 PBAC meeting - Semaglutide (Ozempic)
28 April 2020 - Has Novo Nordisk shot itself in the foot? ...
Posted by Michael Wonder on 26 Apr 2020
Medicines Australia reinforces need for continued collaborative commitment to Australia’s medicine supplies
26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ...
Posted by Michael Wonder on 24 Apr 2020
Recommendations made by the PBAC - March 2020
24 April 2020 - The recommendations from the March 2020 PBAC meeting are now available. ...
Posted by Michael Wonder on 23 Apr 2020
Revised PBS listings for certain antibiotics from 1 May 2020
23 April 2020 - As of 1 May 2020, the Authority Required (STREAMLINED) PBS listings of amoxicillin, amoxicillin with clavulanic acid, ...
Posted by Michael Wonder on 23 Apr 2020
Revised PBS listings for hydroxychloroquine for the treatment of auto-immune disorders and malaria from 1 May 2020
23 April 2020 - Commencing 1 May 2020, the Pharmaceutical Benefits Scheme listings for hydroxychloroquine will change. ...
Posted by Michael Wonder on 21 Apr 2020
Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID‑19 pandemic
22 April 2020 - Prescribing medicines with putative benefit for COVID‑19 disease appears very attractive to consumers, clinicians and some senior ...
Posted by Michael Wonder on 09 Apr 2020
Public Summary Documents - December 2019 PBAC meeting
9 April 2020 - The Public Summary Documents relating to the December 2019 PBAC meeting are now available. ...
Posted by Michael Wonder on 06 Apr 2020
Medicines Australia and the Generic and Biosimilar Medicines Association granted interim authorisation by the ACCC
3 April 2020 - In an important collaborative step, Medicines Australia and the Generic and Biosimilar Medicines Association have today ...
Posted by Michael Wonder on 04 Apr 2020
Controversial malaria drug for COVID-19 cases on way to Australia
4 April 2020 - Australia has secured 2,000 courses of an anti-malaria drug that are to be shipped here and available ...